Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 23Takeda Pharmaceutical

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

LANADELUMAB-FLYO

Brand Name : TAKHZYRO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 300MG/2ML (150MG/ML)

Packaging :

Approval Date :

Application Number : 761090

Regulatory Info :

Registration Country : USA

blank

02

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

LANADELUMAB-FLYO

Brand Name : TAKHZYRO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 300MG/2ML (150MG/ML)

Packaging :

Approval Date :

Application Number : 761090

Regulatory Info :

Registration Country : USA

blank

03

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lanadelumabum

Brand Name : TAKHZYRO

Dosage Form : Solution For Injection

Dosage Strength : 300mg/2ml

Packaging :

Approval Date : 05/11/2020

Application Number : 68178

Regulatory Info : Allowed

Registration Country : Switzerland

blank

04

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lanadelumabum

Brand Name : TAKHZYRO

Dosage Form : Solution For Injection

Dosage Strength : 150mg/ml

Packaging :

Approval Date : 05/11/2020

Application Number : 68178

Regulatory Info : Allowed

Registration Country : Switzerland

blank

05

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lanadelumab

Brand Name : Takhzyro

Dosage Form : Solution For Injection

Dosage Strength : 300mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

06

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lanadelumab

Brand Name : Takhzyro

Dosage Form : Solution For Injection

Dosage Strength : 300mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Not Marketed

Registration Country : Norway

blank

07

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lanadelumab

Brand Name : Takhzyro

Dosage Form : Solution For Injection

Dosage Strength : 150mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

08

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lanadelumab

Brand Name : Takhzyro

Dosage Form : Solution For Injection

Dosage Strength : 300mg/2ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

09

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lanadelumab

Brand Name : Takhzyro

Dosage Form : Solution For Injection

Dosage Strength : 300mg/2ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

10

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lanadelumab

Brand Name : Takhzyro

Dosage Form : Injectable Solution In Pre-Filled Syringe

Dosage Strength : 150MG

Packaging :

Approval Date : 18-01-2024

Application Number : 1181340007

Regulatory Info : Authorized

Registration Country : Spain

blank

11

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lanadelumab

Brand Name : Takhzyro

Dosage Form : Injectable Solution

Dosage Strength : 300MG

Packaging :

Approval Date : 28-03-2019

Application Number : 1181340001

Regulatory Info : Authorized

Registration Country : Spain

blank

12

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lanadelumab

Brand Name : Takhzyro

Dosage Form : Injectable Solution In Pre-Filled Syringe

Dosage Strength : 300MG

Packaging :

Approval Date : 09-09-2020

Application Number : 1181340004

Regulatory Info : Authorized

Registration Country : Spain

blank

13

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lanadelumab

Brand Name : Takhzyro

Dosage Form : Solution For Injection

Dosage Strength : 150mg

Packaging :

Approval Date : 15-11-2023

Application Number : 28106873022

Regulatory Info : Prescription

Registration Country : Denmark

blank

14

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lanadelumab

Brand Name : Takhzyro

Dosage Form : Injectable Solution

Dosage Strength : 300mg

Packaging :

Approval Date : 22-11-2018

Application Number : 28106091818

Regulatory Info : Prescription

Registration Country : Denmark

blank

15

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lanadelumab

Brand Name : Takhzyro

Dosage Form : Solution For Injection

Dosage Strength : 300mg

Packaging :

Approval Date : 07-05-2020

Application Number : 28106517319

Regulatory Info : Prescription

Registration Country : Denmark

blank

16

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lanadelumab

Brand Name : Takhzyro

Dosage Form : Solution For Injection

Dosage Strength : 300mg

Packaging :

Approval Date : 13-02-2025

Application Number : 28107307324

Regulatory Info : Prescription

Registration Country : Denmark

blank

17

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lanadelumab

Brand Name : Takhzyro

Dosage Form : Injectable Solution

Dosage Strength : 300mg

Packaging :

Approval Date : 22-11-2018

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

18

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lanadelumab

Brand Name : Takhzyro

Dosage Form : Solution For Injection

Dosage Strength : 300mg

Packaging :

Approval Date : 07-05-2020

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

19

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lanadelumab

Brand Name : Takhzyro

Dosage Form : Solution For Injection

Dosage Strength : 150mg

Packaging :

Approval Date : 15-11-2023

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

20

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Lanadelumab

Brand Name : Takhzyro

Dosage Form : Solution For Injection

Dosage Strength : 300mg

Packaging :

Approval Date : 13-02-2025

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank